BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32039466)

  • 1. Human papilloma virus-related premalignant and malignant lesions of the cervix and anogenital tract in immunocompromised women.
    Wielgos AA; Pietrzak B
    Ginekol Pol; 2020; 91(1):32-37. PubMed ID: 32039466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL; Joura EA
    BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anal cancer and human papillomaviruses: a perspective based on the cervical cancer model].
    Monsonego J
    Gynecol Obstet Fertil; 2010 Apr; 38(4):250-4. PubMed ID: 20362481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus anogenital disease in HIV-infected individuals.
    Chin-Hong PV; Palefsky JM
    Dermatol Ther; 2005; 18(1):67-76. PubMed ID: 15842614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-like particles for the prevention of human papillomavirus-associated malignancies.
    Wang JW; Roden RB
    Expert Rev Vaccines; 2013 Feb; 12(2):129-41. PubMed ID: 23414405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The advantage of a specialized HPV clinic within the department of proctology].
    Skala K; Zufferey G; Robert-Yap J; Morel P; Roche B
    Rev Med Suisse; 2011 Jun; 7(300):1348-50, 1352-3. PubMed ID: 21815534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients.
    Hinten F; Meeuwis KA; van Rossum MM; de Hullu JA
    Crit Rev Oncol Hematol; 2012 Nov; 84(2):161-80. PubMed ID: 22425015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human Papillomavirus: screening of cervical and anal cancers].
    Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
    Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 16: HPV vaccines in immunocompromised women and men.
    Palefsky JM; Gillison ML; Strickler HD
    Vaccine; 2006 Aug; 24 Suppl 3():S3/140-6. PubMed ID: 16950001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM; Reynolds SM; Jacobson RM
    Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.
    Bacik LC; Chung C
    Int J Dermatol; 2018 Jun; 57(6):627-634. PubMed ID: 29152727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventing cancer: The role of Papillomavirus vaccination in the general population].
    Vié le Sage F; Cohen R
    Bull Cancer; 2020 Jan; 107(1):10-20. PubMed ID: 31982092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradicating HPV-Associated Cancer Through Immunization: A Glass Half Full….
    Frazer IH
    Viral Immunol; 2018 Mar; 31(2):80-85. PubMed ID: 29298130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cervical cancer: Current situation and management in Morocco].
    Belglaiaa E; Mougin C
    Bull Cancer; 2019 Nov; 106(11):1008-1022. PubMed ID: 31606139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.
    Toh ZQ; Licciardi PV; Fong J; Garland SM; Tabrizi SN; Russell FM; Mulholland EK
    Vaccine; 2015 Sep; 33(39):5042-50. PubMed ID: 26271829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and burden of HPV-related disease.
    Serrano B; Brotons M; Bosch FX; Bruni L
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
    Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
    Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.